Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases

Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases

Abstract Hydroxychloroquine and chloroquine, also known as antimalarial drugs, are widely used in the treatment of rheumatic diseases and have recently become the focus of attention because of the ongoing COVID-19 pandemic. Rheumatologists have been using antimalarials to manage patients with chroni...

Full description

Bibliographic Details
Main Authors: Edgard Torres dos Reis Neto, Adriana Maria Kakehasi, Marcelo de Medeiros Pinheiro, Gilda Aparecida Ferreira, Cláudia Diniz Lopes Marques, Licia Maria Henrique da Mota, Eduardo dos Santos Paiva, Gecilmara Cristina Salviato Pileggi, Emília Inoue Sato, Ana Paula Monteiro Gomides Reis, Ricardo Machado Xavier, José Roberto Provenza
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Advances in Rheumatology
Subjects:
Hydroxychloroquine
Chloroquine
Antimalarials
Chronic immune-mediated inflammatory rheumatic diseases
Online Access:http://link.springer.com/article/10.1186/s42358-020-00134-8

Internet

http://link.springer.com/article/10.1186/s42358-020-00134-8

Similar Items